(EMAILWIRE.COM, August 11, 2015 ) GlobalData estimates that the total market size for the 8MM in 2013 was $15.4bn, comprised of $11.0bn in branded drug sales (72%) and $4.4bn in generic sales (28%). GlobalData expects that the dyslipidemia drug market will grow at a CAGR of 9.4% over the ten year…
http://www.emailwire.com/release/195115-Dyslipidemia-Global-Drug-Forecast-and-Market-Analysis-to-2023.html
Dyslipidemia – Global Drug Forecast and Market Analysis to 2023
Related Posts
Recent News
About Us
Market Press Newswire™ provides press release distribution services for businesses,organizations that provide market research reports. The press releases are published
across the webs. Other services include press release writing, editing,consulting and media planning.
Recent Post
Recent Posts
- Military Parachute Market size to Reach USD 2.97 Billion by 2031 Driven by Precision Systems and Rising Defense Demand - Mordor Intelligence
- Mexico Residential Real Estate Market to Reach USD 64.28 Billion by 2031 Driven by Urbanization, Housing Demand, and Policy Reforms
- Global Solvents Market Size to Hit USD 44.30 Billion by 2031 at 4.73% CAGR Amid Rising Low-VOC Adoption
- $422.8 Billion by 2032: 5 Climate & Tech Shifts Reshaping the Homeowner Insurance Market
Contact Us
MarketPressNewswire.net™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC